Matches in Nanopublications for { ?s ?p " Adalimumab is indicated to treat the following conditions: moderately to severely active rheumatoid arthritis in adults. Crohn's disease in patients 6 years of age and older. Moderate to severe chronic plaque psoriasis in adults who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate, as well as those with systemic therapy are less likely to benefit from phototherapy." ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- assertion wasQuotedFrom " Adalimumab is indicated to treat the following conditions: moderately to severely active rheumatoid arthritis in adults. Crohn's disease in patients 6 years of age and older. Moderate to severe chronic plaque psoriasis in adults who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate, as well as those with systemic therapy are less likely to benefit from phototherapy." provenance.